SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Pharmaceuticals and Chemicals has informed that the Board of Directors of the Company at its meeting held on August 22, 2015, has recommended the final dividend at the rate of 100% (i.e. Rs 2.00 per equity share of Rs 2.00 each) on the paid-up equity share capital of the Company for the financial year 2014-2015. Audit Committee and Board have recommended appointment of V. D. Shukla & Co., Chartered Accountant, Ahmedabad and Haribhakti & Co. LLP, Chartered Accountants, Mumbai as Joint Statutory Auditors of the Company for the financial year 2015-16.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×